...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Pharmacophore-based virtual screening and Bayesian model for the identification of potential human leukotriene A4 hydrolase inhibitors.
【24h】

Pharmacophore-based virtual screening and Bayesian model for the identification of potential human leukotriene A4 hydrolase inhibitors.

机译:基于药理学的虚拟筛选和贝叶斯模型,用于鉴定潜在的人类白三烯A4水解酶抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Leukotriene A4 hydrolase (LTA4H), an enzyme involved in the conversion of LTA4 to LTB4, is an emerging and important anti-inflammatory target. This study demonstrates the development of quantitative pharmacophore hypothesis and Bayesian model and their applications in identification of potential human LTA4H (hLTA4H) inhibitors. The best hypothesis with a high correlation coefficient value of 0.951 was validated using different methods including a test set containing 136 compounds. It was further used as a three-dimensional query in database searching to retrieve virtual leads for hLTA4H inhibition. Molecular docking study was employed to identify the compounds that bind the active site with high affinity. Developed Bayesian model suggested molecular features favoring and not favoring the inhibition of hLTA4H.
机译:白三烯A4水解酶(LTA4H)是一种涉及LTA4转化为LTB4的酶,是一种新兴的重要抗炎靶标。这项研究证明了定量药效团假说和贝叶斯模型的发展及其在鉴定潜在的人LTA4H(hLTA4H)抑制剂中的应用。使用不同的方法(包括包含136种化合物的测试集)验证了具有0.951的高相关系数值的最佳假设。在数据库搜索中,它还被用作三维查询,以检索虚拟线索来抑制hLTA4H。分子对接研究用于鉴定以高亲和力结合活性位点的化合物。发达的贝叶斯模型表明分子特征有利于而不利于抑制hLTA4H。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号